Shete P B, Nalugwa T, Farr K, Ojok C, Nantale M, Howlett P, Haguma P, Ochom E, Mugabe F, Joloba M, Chaisson L H, Dowdy D W, Moore D, Davis J L, Katamba A, Cattamanchi A
Division of Pulmonary and Critical Care Medicine, University of California San Francisco and Zuckerberg San Francisco General Hospital, San Francisco, Curry International Tuberculosis Center, University of California San Francisco, San Francisco, California, USA.
School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Int J Tuberc Lung Dis. 2017 Jul 1;21(7):746-752. doi: 10.5588/ijtld.16.0699.
To assess the feasibility of a streamlined strategy for improving tuberculosis (TB) diagnostic evaluation and treatment initiation among patients with presumed TB.
Single-arm interventional pilot study at five primary care health centers of a streamlined, SIngle-saMPLE (SIMPLE) TB diagnostic evaluation strategy: 1) examination of two smear results from a single spot sputum specimen using light-emitting diode fluorescence microscopy, and 2) daily transportation of smear-negative sputum samples to Xpert® MTB/RIF testing sites.
Of 1212 adults who underwent sputum testing for TB, 99.6% had two smears examined from the spot sputum specimen. Sputum was transported for Xpert testing within 1 clinic day for 83% (907/1091) of the smear-negative patients. Of 157 (13%) patients with bacteriologically positive TB, 116 (74%) were identified using sputum smear microscopy and 41 (26%) using Xpert testing of smear-negative samples. Anti-tuberculosis treatment was initiated in 142 (90%) patients with bacteriologically positive TB, with a median time to treatment of 1 day for smear-positive patients and 6 days for smear-negative, Xpert-positive patients.
The SIMPLE TB strategy led to successful incorporation of Xpert testing and rapid treatment initiation in the majority of patients with bacteriologically confirmed TB in a resource-limited setting.
评估一种简化策略在疑似结核病患者中改善结核病诊断评估及启动治疗的可行性。
在五个基层医疗保健中心开展的单臂干预性试点研究,采用一种简化的单样本(SIMPLE)结核病诊断评估策略:1)使用发光二极管荧光显微镜检查单个痰标本的两份涂片结果;2)将涂片阴性的痰标本每日运送至Xpert® MTB/RIF检测点。
在1212名接受结核病痰检的成年人中,99.6%的患者对单个痰标本进行了两份涂片检查。83%(907/1091)涂片阴性的患者在1个诊日内将痰标本运送至Xpert检测点。在157名(13%)细菌学确诊结核病的患者中,116名(74%)通过痰涂片显微镜检查确诊,41名(26%)通过对涂片阴性样本进行Xpert检测确诊。142名(90%)细菌学确诊结核病的患者开始接受抗结核治疗,涂片阳性患者开始治疗的中位时间为1天,涂片阴性且Xpert检测阳性的患者为6天。
在资源有限的环境中,SIMPLE结核病策略使大多数细菌学确诊结核病的患者成功纳入Xpert检测并迅速开始治疗。